Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
deCODE genetics: A sequence variant that increases risk of pregnancy loss 2024-01-29 18:00
Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition 2023-11-07 00:00
Large-scale proteomics in population-based studies from UK and Iceland 2023-10-04 23:00
deCODE genetics: Predicting the probability of death 2021-06-18 17:00
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis 2021-06-01 16:00
Loss of Function Variant in FLT3 Strongly Increases the Risk of Autoimmune Thyroid Disease and Other Autoimmune Diseases 2020-06-24 23:00
Lowering LDL Levels with Repatha(R) (evolocumab) Did Not Adversely Affect Cognitive Function in Landmark Phase 3 Study 2017-03-20 16:55
Landmark Outcomes Study Shows that Repatha(R) (evolocumab) Decreases LDL-C to Unprecedented Low Levels and Reduces Risk of Cardiovascular Events with No New Safety Issues 2017-03-20 15:28
Amgen Opens Next-generation Biomanufacturing Facility in Singapore 2014-11-20 11:00
1